Talking about what others are afraid to say
The pharma industry’s latest lawsuit against Medicare’s most-favored-nation pricing experiment reveals just how far drugmakers will go to protect their pricing power, illustrating a fierce commitment to maintaining profit margins …
PhRMA Is Suing to Keep Drug Prices High. Once Again, Patients Are Paying the Price Read More
Ask pharma executives about their companies, and you’ll hear familiar language: patients first, innovation, collaboration, purpose, people. Ask employees anonymously on Reddit, and you enter a very different pharma industry. Let …
Pharma Employees Have Some Thoughts On Worst Employer Read More
It’s easy to be angry at the pharma industry right now, and honestly, a lot of that anger is earned. But I want to start somewhere that often gets lost …
Can We Balance Profit and Patient Care in Pharma? Read More
So you get a cancer diagnosis. You’ll be offered surgery and chemo, maybe radiation or immunotherapy or hormone therapy for many years. All of this will be paid for by …
Exercise Can Improve Survival in Cancer Patients. Why Does Insurance Not Cover It? Read More
These days, Republicans and Democrats can’t find much common ground. Not even the color of the sky. But lately they seem to agree on one subject: something needs to change …
PBMs Have Accomplished the Impossible: They United Republicans and Democrats Read More
Last month, a friend of mine got a $2,300 bill. She had insurance, went to an in-network hospital, and the visit lasted about forty minutes. Nobody could tell her why …
Healthcare Costs Are Out of Control, and People Are Done Waiting Read More
The pharma industry has poured billions into educating physicians and patients that GLP-1’s can alter your life. Plenty of data backs this up. What pharma should be asking is. What …
Writing an Rx for a GLP-1 Drug isn’t Good Enough Read More
For decades, the pharma launch formula was relatively straightforward: hire a large sales force, buy mountains of data, flood physicians with promotion, spend heavily on conferences, hire agencies, build patient …
Rethinking Pharma Launch Costs for Better Results Read More